Ionis to participate in virtual fireside chat at H.C. Wainwright 1st Annual Hereditary Angioedema Conference

Rhea-AI Summary

Ionis Pharmaceuticals (Nasdaq: IONS) will participate in a virtual fireside chat at the H.C. Wainwright 1st Annual Hereditary Angioedema Conference on July 20, 2022. Investors can access the live webcast on the Ionis website; a replay will be available within 48 hours post-event. Ionis has been a leader in RNA-targeted therapy for over 30 years, with a strong pipeline and three marketed medicines. The company aims to revolutionize standards of care through innovative therapies.

CARLSBAD, Calif., July 13, 2022 /PRNewswire/ -- Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that management will participate in a virtual fireside chat at the H.C. Wainwright 1st Annual Hereditary Angioedema (HAE) Conference on Wednesday, July 20, 2022.

A live webcast and additional information about this fireside chat can be accessed on the Investors & Media section of the Ionis website at www.ionispharma.com. A replay will be available on the Ionis website within 48 hours of this event.

About Ionis Pharmaceuticals, Inc.
For more than 30 years, Ionis has been the leader in RNA-targeted therapy, pioneering new markets and changing standards of care with its novel antisense technology. Ionis currently has three marketed medicines and a premier late-stage pipeline highlighted by industry-leading cardiovascular and neurological franchises. Our scientific innovation began and continues with the knowledge that sick people depend on us, which fuels our vision of becoming a leading, fully integrated biotechnology company.

To learn more about Ionis, visit www.ionispharma.com and follow us on Twitter @ionispharma.

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/ionis-to-participate-in-virtual-fireside-chat-at-hc-wainwright-1st-annual-hereditary-angioedema-conference-301585143.html

SOURCE Ionis Pharmaceuticals, Inc.

FAQ

When will Ionis participate in the H.C. Wainwright 1st Annual Hereditary Angioedema Conference?

Ionis Pharmaceuticals will participate in the conference on July 20, 2022.

How can I access the live webcast of Ionis' fireside chat?

The live webcast can be accessed on the Investors & Media section of the Ionis website.

Will there be a replay available for Ionis' fireside chat?

Yes, a replay will be available on the Ionis website within 48 hours after the event.

What are Ionis Pharmaceuticals' key focuses in their pipeline?

Ionis focuses on RNA-targeted therapy with strong cardiovascular and neurological franchises.